Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells

被引:210
作者
Song, LX
Coppola, D
Livingston, S
Cress, D
Haura, EB
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Expt Therapeut & Thorac Oncol Program, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA
[3] Univ S Florida, Coll Med, Dept Interdisciplinary Oncol, Tampa, FL USA
[4] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL USA
关键词
Bcl-2; proteins; Mcl-1; lung cancer; apoptosis; epidermal growth factor receptor; chemotherapy;
D O I
10.4161/cbt.4.3.1496
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overexpression of anti-apoptotic Bcl-2 family members and deregulation of the pathways that regulate pro-apoptotic family members have been observed in non-small cell lung cancers (NSCLC). Previous reports have identified both Bcl-2 and Bcl-x(L) proteins as survival factors in lung cancer cells since reductions in these proteins can induce apoptosis and sensitize lung cancer cells to apoptosis induced by chemotherapy agents.. Myeloid cell leukemia-1 (Mcl-1), another member of the Bcl-2 family, has been found to be a critical survival factor in hematopoietic cells, yet little data exists for a role of Mcl-1 in human lung cancers. We used NSCLC cell lines to explore how Mcl-1 levels affect lung cancer cell survival and studied tumors from patients to determine expression patterns of Mcl-1. NSCLC cells express abundant Mcl-1 protein and depletion of Mcl-1 levels by antisense Mcl-1 oligonucleotides induces apoptosis in A549 and H 1299 lung cancer cells. Reduction in Mcl-1 levels can sensitize lung cancer cells to apoptosis induced by cytotoxic agents as well as by ionizing radiation. Lung cancer cells overexpressing Mcl-1 are less sensitive to apoptosis induced by chemotherapeutic agents, ZD1839 (an inhibitor of EGFR tyrosine kinase) and Bcl-2 or Bcl-x(L) antisense oligonucleotides. We find that epidermal growth factor (EGF) can enhance Mcl-1 protein levels in an ERK-dependent manner. m Signal transduction agents that reduce Mcl-1 levels correlated with their individual ability to induce apoptosis in lung cancer cells. Finally, NSCLC tumors taken directly from patients have elevated levels of Mcl-1 protein compared with normal adjacent lung tissue. Therefore, agents that target Mcl-1 can induce apoptosis and sensitize cells to apoptosis induced by cytotoxic agents. Mcl-1 protein is overexpressed in a subset of human NSCLC and enhanced levels of Mcl-1 may protect lung cancer cells from death induced by a variety of pro-apoptotic stimuli.
引用
收藏
页码:267 / 276
页数:10
相关论文
共 64 条
[1]   Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: Analysis of 427 cases [J].
Anton, RC ;
Brown, RW ;
Younes, M ;
Gondo, MM ;
Stephenson, MA ;
Cagle, PT .
HUMAN PATHOLOGY, 1997, 28 (09) :1079-1082
[2]   Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer [J].
Apolinario, RM ;
vanderValk, P ;
deJong, JS ;
Deville, W ;
vanArkOtte, J ;
Dingemans, AMC ;
vanMourik, JC ;
Postmus, PE ;
Pinedo, HM ;
Giaccone, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2456-2466
[3]   Down-regulation of Mcl-1 by inhibition of the P13-K/Akt pathway is required for cell shrinkage-dependent cell death [J].
Araki, T ;
Hayashi, M ;
Watanabe, N ;
Kanuka, H ;
Yoshino, J ;
Miura, M ;
Saruta, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (04) :1275-1281
[4]  
Banerjee D, 2001, Curr Opin Investig Drugs, V2, P574
[5]  
Banerjee D, 1999, CURR OPIN MOL THER, V1, P404
[6]   Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors [J].
Bianco, R ;
Shin, I ;
Ritter, CA ;
Yakes, FM ;
Basso, A ;
Rosen, N ;
Tsurutani, J ;
Dennis, PA ;
Mills, GB ;
Arteaga, CL .
ONCOGENE, 2003, 22 (18) :2812-2822
[7]   Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small cell lung cancer [J].
Borner, MM ;
Brousset, P ;
Pfanner-Meyer, B ;
Bacchi, M ;
Vonlanthen, S ;
Hotz, MA ;
Altermatt, HJ ;
Schlaifer, D ;
Reed, JC ;
Betticher, DC .
BRITISH JOURNAL OF CANCER, 1999, 79 (5-6) :952-958
[8]  
Ciardiello F, 2000, CLIN CANCER RES, V6, P2053
[9]   Direct repression of the Mcl-1 promoter by E2F1 [J].
Croxton, R ;
Ma, YH ;
Song, LX ;
Haura, EB ;
Cress, WD .
ONCOGENE, 2002, 21 (09) :1359-1369
[10]   Antisense strategy shows that Mcl-1 rather than Bcl-2 or BCI-xL is an essential survival protein of human myeloma cells [J].
Derenne, S ;
Monia, B ;
Dean, NM ;
Taylor, JK ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R ;
Amiot, M .
BLOOD, 2002, 100 (01) :194-199